Profil
Albertien Greijdanus was the founder of Alleviant Medical, Inc. and held the title of Director & Chief Compliance Officer since its founding in 2017.
Ms. Greijdanus is currently a Senior Investment Manager at Brabantse Ontwikkelings Maatschappij Holding BV, starting in 2024.
Education includes an undergraduate degree from Delft University of Technology conferred in 2008 and a graduate degree conferred in 2011.
Aktive Positionen von Albertien Greijdanus
| Unternehmen | Position | Beginn |
|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest. | Private Equity Investor | 01.01.2024 |
Ehemalige bekannte Positionen von Albertien Greijdanus
| Unternehmen | Position | Ende |
|---|---|---|
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Gründer | - |
Ausbildung von Albertien Greijdanus
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest. | Finance |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Commercial Services |
















